Commentary - Saxagliptine is non-inferior to gipizide in partients with type 2 diabetes mellitus

Abstract

Annotation - The article comments (prof. Svačina) to a new clinical study with DPP-4 inhibitor saxagliptin.

Keywords

• Diabetology
• internal medicine